Respiratory Syncytial Virus–Associated Hospital Admissions and Bed Days in Children <5 Years of Age in 7 European Countries

Author:

Wang Xin12ORCID,Li You12ORCID,Vazquez Fernandez Liliana3,Teirlinck Anne C4,Lehtonen Toni56,van Wijhe Maarten7,Stona Luca8,Bangert Mathieu9,Reeves Rachel M1,Bøås Håkon10,van Boven Michiel4ORCID,Heikkinen Terho611,Klint Johannesen Caroline12,Baraldi Eugenio13,Donà Daniele13,Tong Sabine9,Campbell Harry1ORCID,Reeves Rachel M,Li You,Wang Xin,Campbell Harry,Nair Harish,van Wijhe Maarten,Fischer Thea Kølsen,Simonsen Lone,Trebbien Ramona,Johannesen Caroline Klint,Tong Sabine,Bangert Mathieu,Demont Clarisse,Lehtonen Toni,Heikkinen Terho,Teirlinck Anne C,van Boven Michiel,van der Hoek Wim,van der Maas Nicoline,Meijer Adam,Fernandez Liliana Vazquez,Bøås Håkon,Bekkevold Terese,Flem Elmira,Stona Luca,Speltra Irene,Giaquinto Carlo,Baraldi Eugenio,Donà Daniele,Cheret Arnaud,Leach Amanda,Stoszek Sonia,Beutels Philippe,Bont Louis,Pollard Andrew,Openshaw Peter,Abram Michael,Swanson Kena,Rosen Brian,Molero Eva,

Affiliation:

1. Centre for Global Health, University of Edinburgh, Edinburgh, United Kingdom

2. School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China

3. Department of Methods Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway

4. Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands

5. Finnish Institute for Health and Welfare, Helsinki, Finland

6. Turku University Hospital, Turku, Finland

7. Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark

8. Fondazione Penta ONLUS, Padova, Italy

9. Sanofi Pasteur, Lyon, France

10. Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Oslo, Norway

11. University of Turku, Turku, Finland

12. Nordsjællands Hospital, Hillerød, Denmark

13. Dipartimento di Salute della Donna e del Bambino, Università di Padova, Padova, Italy

Abstract

Abstract Background Respiratory syncytial virus (RSV) is a leading cause of respiratory tract infections (RTIs) in young children. High-quality country-specific estimates of bed days and length of stay (LOS) show the population burden of RSV-RTI on secondary care services and the burden among patients, and can be used to inform RSV immunization implementation decisions. Methods We estimated the hospital burden of RSV-associated RTI (RSV-RTI) in children under 5 years in 7 European countries (Finland, Denmark, Norway, Scotland, England, the Netherlands, and Italy) using routinely collected hospital databases during 2001–2018. We described RSV-RTI admission rates during the first year of life by birth month and assessed their correlation with RSV seasonality in 5 of the countries (except for England and Italy). We estimated average annual numbers and rates of bed days for RSV-RTI and other-pathogen RTI, as well as the hospital LOS. Results We found that infants born 2 months before the peak month of RSV epidemics more frequently had the highest RSV-RTI hospital admission rate. RSV-RTI hospital episodes accounted for 9.9–21.2 bed days per 1000 children aged &lt;5 years annually, with the median (interquartile range) LOS ranging from 2 days (0.5–4 days) to 4 days (2–6 days) between countries. Between 70% and 89% of these bed days were in infants aged &lt;1 year, representing 40.3 (95% confidence interval [CI], 40.1–40.4) to 91.2 (95% CI, 90.6–91.8) bed days per 1000 infants annually. The number of bed days for RSV-RTI was higher than that for RTIs associated with other pathogens in infants aged &lt;1 year, especially in those &lt;6 months. Conclusions RSV disease prevention therapies (monoclonal antibodies and maternal vaccines) for infants could help prevent a substantial number of bed days due to RSV-RTI. "High-risk" birth months should be considered when developing RSV immunization schedules. Variation in LOS between countries might reflect differences in hospital care practices.

Funder

Innovative Medicines Initiative 2 Joint Undertaking

European Union’s Horizon 2020 Research and Innovation Programme

European Federation of Pharmaceutical Industries and Associations

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3